About
Moleculera Biosciences develops blood-based autoantibody testing panels and biomarker assays to identify immune-mediated causes of neuropsychiatric, cardiovascular, and Alzheimer's-related disorders enabling precision diagnosis and personalized treatment.
Explore Moleculera Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.